Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 19 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 11746152

    Methods of cancer treatment and therapy using a combination of antibodies that bind glycosylated PD-L1

    The Board of Regents of the University of Texas System · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  2. US 11737993

    Multiple myeloma treatment

    VANDA PHARMACEUTICALS INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  3. US 11738009

    Bicyclic compounds and their use in the treatment of cancer

    TEMPEST THERAPEUTICS, INC. · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  4. US 11737978

    Compositions and methods of using propylene sulfide-based polymers for treatment of Chagas disease

    Northwestern University · Granted Aug 29, 2023 · Expires Aug 24, 2043

    granted
  5. US 11730775

    Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof

    Seres Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  6. US 11730739

    Treatment of congenital adrenal hyperplasia

    Neurocrine Biosciences, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  7. US 11723881

    Fortified CBD oil for treatment of PTSD

    Bright Green Corporation · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  8. US 11723903

    Treatment of schizophrenia

    VANDA PHARMACEUTICALS INC. · Granted Aug 15, 2023 · Expires Aug 10, 2043

    granted
  9. US 11717547

    Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

    Krystal Biotech, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  10. US 11717573

    Methods and compositions for the treatment of cancer

    SOUTH DAKOTA BOARD OF REGENTS · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  11. US 11718612

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  12. US 11718616

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  13. US 11712427

    Method for increasing serum adiponectin for treatment and reduction of the risk of cardiovascular, vascular, and related diseases

    FIRST FRUITS BUSINESS MINISTRY, LLC · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  14. US 11713461

    Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  15. US 11713292

    Treatment of cataplexy

    AXSOME MALTA LTD. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  16. US 11708415

    Treatment and inhibition of inflammatory lung diseases in patients having risk alleles in the genes encoding IL33 and IL1RL1

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  17. US 11707472

    Compositions for the treatment of fibrosis

    Viking Therapeutics, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  18. US 11701431

    Hydrogel prodrug for treatment

    Viking Scientific, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  19. US 11701331

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  20. US 11701341

    Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide in the treatment of acute exacerbations of chronic obstructive pulmonary disease

    MEREO BIOPHARMA 1 LIMITED · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted
  21. US 11697667

    Salts and polymorphs of cethromycin for the treatment of disease

    AliquantumRx, Inc. · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted
  22. US 11696896

    Immunomodulatory nanoparticle treatment of brain injury

    Northwestern University · Granted Jul 11, 2023 · Expires Jul 6, 2043

    granted
  23. US 11692229

    Fast diagnosis and personalized treatments for acne

    The Regents of the University of California · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted
  24. US 11690839

    Treatment of idiopathic pulmonary fibrosis

    TAKEDA GMBH · Granted Jul 4, 2023 · Expires Jun 29, 2043

    granted